Growth Metrics

BeOne Medicines (ONC) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for BeOne Medicines (ONC) over the last 10 years, with Q3 2025 value amounting to 0.71.

  • BeOne Medicines' Asset Utilization Ratio rose 2422.44% to 0.71 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.71, marking a year-over-year increase of 2422.44%. This contributed to the annual value of 0.65 for FY2024, which is 4915.36% up from last year.
  • Latest data reveals that BeOne Medicines reported Asset Utilization Ratio of 0.71 as of Q3 2025, which was up 2422.44% from 0.75 recorded in Q2 2025.
  • Over the past 5 years, BeOne Medicines' Asset Utilization Ratio peaked at 0.75 during Q2 2025, and registered a low of 0.11 during Q1 2022.
  • Over the past 5 years, BeOne Medicines' median Asset Utilization Ratio value was 0.31 (recorded in 2023), while the average stood at 0.38.
  • In the last 5 years, BeOne Medicines' Asset Utilization Ratio surged by 25030.41% in 2021 and then tumbled by 2986.77% in 2022.
  • Quarter analysis of 5 years shows BeOne Medicines' Asset Utilization Ratio stood at 0.17 in 2021, then skyrocketed by 36.29% to 0.23 in 2022, then soared by 87.09% to 0.43 in 2023, then surged by 49.41% to 0.65 in 2024, then increased by 10.09% to 0.71 in 2025.
  • Its last three reported values are 0.71 in Q3 2025, 0.75 for Q2 2025, and 0.71 during Q1 2025.